BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ERG, P11308, 2078
26 results:

  • 1. Synchronous Double Primary Angiosarcoma Originating from the Stomach and Rectum: A Case Report and a Literature Review.
    Kapagan T; Bulut N; Erdem GU; Yıldırım S; Erdem ZB; Sahin H
    Arch Iran Med; 2024 Mar; 27(3):168-173. PubMed ID: 38685842
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Usefulness of Elastin Staining to Detect Vascular Invasion in cancer.
    Gonzalez J; Bahmad HF; Ocejo S; Abreu A; Popp M; Gogola S; Fernandez V; Recine M; Poppiti R
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894944
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Intercellular adhesion molecule 2 as a novel prospective tumor suppressor induced by erg promotes ubiquitination-mediated radixin degradation to inhibit gastric cancer tumorigenicity and metastasis.
    Tang X; Huang J; Jiang Y; Qiu J; Li T; Li W; Chen Z; Huang Z; Yu X; Yang T; Ji X; Tan R; Lv L; Yang Z; Chen H
    J Transl Med; 2023 Sep; 21(1):670. PubMed ID: 37759298
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification of an EMT-related Gene Signature Predicting Recurrence in Stage II/III colorectal cancer: A Retrospective Study in 1780 Patients.
    Ren H; Bösch F; Pretzsch E; Jacob S; Westphalen CB; Walter Holch J; Werner J; Angele MK
    Ann Surg; 2022 Nov; 276(5):897-904. PubMed ID: 35880752
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Histopathological and genetic features of mismatch repair-deficient high-grade prostate cancer.
    Wyvekens N; Tsai HK; Sholl LM; Tucci J; Giannico GA; Gordetsky JB; Hirsch MS; Barletta JA; Acosta AM
    Histopathology; 2022 Jun; 80(7):1050-1060. PubMed ID: 35395112
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Hypermucinous, Goblet Cell-Deficient and Crypt Cell Dysplasias in Inflammatory Bowel Disease are Often Associated with Flat/Invisible Endoscopic Appearance and Advanced Neoplasia on Follow-Up.
    Choi WT; Salomao M; Zhao L; Alpert L; Setia N; Liao X; Drage MG; Westerhoff M; Cheng J; Lauwers GY; Ko HM
    J Crohns Colitis; 2022 Jan; 16(1):98-108. PubMed ID: 34232295
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
    Naderi A
    Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Revised Danish guidelines for the cancer surveillance of patients with Cowden Syndrome.
    Smerdel MP; Skytte AB; Jelsig AM; Ebbehøj E; Stochholm K
    Eur J Med Genet; 2020 May; 63(5):103873. PubMed ID: 32058060
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Down-Regulation of LINC00460 Represses Metastasis of colorectal cancer via WWC2.
    Yuan B; Yang J; Gu H; Ma C
    Dig Dis Sci; 2020 Feb; 65(2):442-456. PubMed ID: 31541369
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Epithelioid Hemangioendothelioma of the Bowel in Crohn's Disease: The First Reported Case.
    Spasic S; Brcic I; Freire R; Garcia-Buitrago MT; Rosenberg AE
    Int J Surg Pathol; 2019 Jun; 27(4):423-426. PubMed ID: 30238810
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer.
    Jarzabek MA; Proctor WR; Vogt J; Desai R; Dicker P; Cain G; Raja R; Brodbeck J; Stevens D; van der Stok EP; Martens JWM; Verhoef C; Hegde PS; Byrne AT; Tarrant JM
    PLoS One; 2018; 13(6):e0198099. PubMed ID: 29879147
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Trifluridine-Tipiracil for Previously Treated Metastatic colorectal cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Ramaekers BLT; Wolff R; van Giessen A; Pouwels X; Fayter D; Lang S; Armstrong N; Worthy G; Duffy S; Kleijnen J; Joore MA
    Pharmacoeconomics; 2018 Mar; 36(3):285-288. PubMed ID: 29177842
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective.
    Sagar B; Lin YS; Castel LD
    J Med Econ; 2017 Oct; 20(10):1018-1023. PubMed ID: 28581874
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. miR-145 suppresses colorectal cancer cell migration and invasion by targeting an ETS-related gene.
    Li S; Wu X; Xu Y; Wu S; Li Z; Chen R; Huang N; Zhu Z; Xu X
    Oncol Rep; 2016 Oct; 36(4):1917-26. PubMed ID: 27572146
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Effect of a Financial Incentive for colorectal cancer Screening Adherence on the Appropriateness of Colonoscopy Orders.
    Morland TB; Synnestvedt M; Honeywell S; Yang F; Armstrong K; Guerra C
    Am J Med Qual; 2017; 32(3):292-298. PubMed ID: 27259869
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The Clinical and Cost Effectiveness of Aflibercept in Combination with Irinotecan and Fluorouracil-Based Therapy (FOLFIRI) for the Treatment of Metastatic colorectal cancer Which has Progressed Following Prior Oxaliplatin-Based Chemotherapy: a Critique of the Evidence.
    Wade R; Duarte A; Simmonds M; Rodriguez-Lopez R; Duffy S; Woolacott N; Spackman E
    Pharmacoeconomics; 2015 May; 33(5):457-66. PubMed ID: 25616671
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.
    Epstein JI; Egevad L; Humphrey PA; Montironi R;
    Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Bevacizumab for metastatic colorectal cancer: a NICE single technology appraisal.
    Whyte S; Pandor A; Stevenson M
    Pharmacoeconomics; 2012 Dec; 30(12):1119-32. PubMed ID: 23058097
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Atypical cribriform lesions of the prostate: clinical significance, differential diagnosis and current concept of intraductal carcinoma of the prostate.
    Shah RB; Zhou M
    Adv Anat Pathol; 2012 Jul; 19(4):270-8. PubMed ID: 22692290
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer.
    Whyte S; Pandor A; Stevenson M; Rees A
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):47-53. PubMed ID: 21047491
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.